Article
Isorhapontigenin is a novel potential therapeutic agent for lung cancer: evidence from network pharmacology, bioinformatics, molecular docking and in vitro experiments
2025-02-04
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Isorhapontigenin is an effective active ingredient in rheum officinale, which has been reported to have anti-tumor effects. However, its effect and molecular mechanism on non-small cell lung cancer are still unclear. <bold>Methods</bold>: Firstly, potential therapeutic targets of Isorhapontigenin against non-small cell lung cancer were obtained through network p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0c68dcbc-38b3-5750-98b4-4f7c99a9ed2d
- DOI
- 10.21203/rs.3.rs-5882443/v1
